Join
A global consensus on lifestyle as medicine.
Sharon Bergquist
MD, FACP

Dr. Sharon Horesh Bergquist is a Rollins Distinguished Clinician and assistant professor of medicine at Emory University in Atlanta, Georgia. She is a nationally recognized clinician, educator, and advocate in the fields of preventive medicine and healthy aging.

Dr. Bergquist graduated summa cum laude from Yale College in molecular biophysics and biochemistry. She attended Harvard Medical School and completed her internship and residency at Harvard’s Brigham and Women’s Hospital in Boston. Additionally, she has received several fellowships to study and research alternative medicine at the University of Tokyo in Japan.

Currently investigating early predictive markers and novel treatments for cardiovascular disease, cancer, Alzheimer’s, and other age-related chronic diseases with the most advanced genomic, microbiomic, epigenetic, and imaging technologies, she is on the team leading the largest clinical study ever conducted in Atlanta. Her research interest is in using predictive markers to guide an individualized and integrated lifestyle approach to heathy aging.

Dr. Bergquist combines evidence-based lifestyle medicine with leveraging the intimate connection between the mind and body in her internal medicine and executive health practices. She has earned national recognition in multiple years as one of America’s Top Physicians by the Consumer Research Council of America. In 2012, she was among a select group of physician leaders invited to The White House to brainstorm on healthcare reform.

As a frequent expert resource, she has contributed to over a hundred television, print, and radio segments, including for Good Morning America, CNN, ABC News, NBC News, FOX News Network, The Wall Street Journal, NPR, and Georgia Public Broadcasting. She is a former consulting medical editor for WebMD and has created educational videos with TED and the Centers for Disease Control. Turknett Leadership Group has named her a “Woman Leader for the New Millennium.”

X
LEARN MORE
Support Us